Biomolecular Condensates in Biology & Disease

Biomolecular Condensates in Biology & Disease

University

St. Jude

Presenter

Dr. Richard Kriwacki

Head-and-shoulders portrait of a person with gray hair and a mustache wearing a blue collared shirt against a dark gray background.

 

During his >25 year career, Richard Kriwacki has sought to understand the molecular basis of regulation of essential biological processes (e.g., cell division, apoptosis, ribosome biogenesis, and transcription) with emphasis on the roles of intrinsically disordered proteins (IDPs) and phase separation in these processes. The lab applies structural biology and biophysical techniques (NMR spectroscopy, x-ray crystallography, calorimetry, AUC, etc.), as well as biochemical, cell biological and cell imaging methods, to study the details of biomolecular mechanisms from the test tube to cells.

One research direction focuses on the role of phase separation in biology & disease, specifically the role of Nucleophosmin (NPM1) and other proteins in the structure, dynamics and function of the liquid-like membrane-less organelle, the nucleolus. A primary goal is to understand how phase separation contributes to the molecular steps underlying ribosome biogenesis.

Schematic titled "Ribosome subunit assembly through multiple GC sub-phases" showing unassembled rRNA progressing through SURF6- and NPM1-associated assembly intermediates to assembled ribosomal subunits. Arrows indicate movement through multiple condensate-like sub-phases from left to right.

Another research direction addresses the role of phase separation by fusion oncoproteins (FOs) in cancer. We discovered that some FOs would undergo phase separation (PS) in the nuclei of cells, forming aberrant transcription centers that drive aberrant gene expression and transform cells. Broadly, we seek to understand the prevalence of phase separation by FO across diverse pediatric cancers and to apply this knowledge to advance cancer therapeutics.

Three-panel schematic showing a fluorescence microscopy study of 166 mEGFP-tagged fusion oncoproteins, classified by whether they form puncta and by their nuclear or cytoplasmic localization, physicochemical features, and biological functions. A feature-based model then predicts condensation behavior for 2,999 untested fusion oncoproteins, with 67% predicted to form puncta and 33% predicted not to form puncta, along with predicted localization and function.